Serum Levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease Severity
By O. Arican, M. Aral, S. Şaşmaz, P. Çıragil. Mediators of Inflammation, 2005
647 citations recorded by the source corpus.
Recent progress in the understanding of psoriasis has shown that the regulation of local and systemic cytokines plays an important role in its pathogenesis. The most often used psoriasis score is the psoriasis area and severity index (PASI). A simple laboratory test from a blood sample would be an attractive, patient-independent, and observer-independent marker of disease severity. To this end, we evaluated the association of serum levels of some proinflammatory cytokines in vivo and their correlation with severity of psoriasis. The serum levels of cytokines levels were determined with the use of the ELISA method. All mean values except IL-17 levels of patients were significantly higher than those of controls. There was a significant correlation between serum levels of IFN-γ, IL-12, IL-17, and IL-18, and severity of the disease. Psoriasis can be described as a T-cell-mediated disease, with a complex role for a variety of cytokines, which has led to the development of new immunomodulatory therapies. In this study, serum TNF-α, IFN-γ, IL-6, IL-8, IL-12, and IL-18 levels were significantly higher in active psoriatic patients than in controls. Furthermore, high levels of IFN-γ, IL-12, and IL-18 correlated with the clinical severity and activity of psoriasis, and those measurements of serum levels of these cytokines may be objective parameters for the disease severity.
Subfields: Complementary and Manual Therapy, Dermatology, Immunology
View Paper: https://www.semanticscholar.org/paper/d0a1dc712a60468733a99499b35d2642aaf8feb2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Dermatology
In Immunology
Citations in the corpus
- The IL-23/Th17 axis in the immunopathogenesis of psoriasis. (2009, background): “…1999), systemic lupus erythematosus (Wong et al., 2000), and systemic sclerosis (Kurasawa et al., 2000), no statistically significant differences in peripheral levels of IL-17A have been found in psoriatic patients when www.jidonline.org 1343 compared with that in controls (Arican et al., 2005).”